Medical Biotechnology and Molecular Medicine
In-person programme
Medical Biotechnology and Molecular Medicine
Course sheet
A.Y. 2026/2027
Master programme
LM-9 R - Biotecnologie mediche, veterinarie e farmaceutiche
The Master's program in Medical Biotechnology and Molecular Medicine aims to train professionals with a solid technical and theoretical background. Their expected career development will be to develop scientific methodologies and coordinate research projects in the fields of applied biotechnology and translational medicine. The Master's program will provide students with a solid background in the genetic and molecular bases of diseases and the physiopathological mechanisms occurring in human beings in disease states, in order to develop biotechnology-based diagnostic and therapeutic strategies. This knowledge will be complemented with specific training in the fields of computer science, biophysics, nanotechnology and pharmacology. The Master's program is organised in common and curricular learning activities focusing on neuroscience, oncology, molecular diagnostics, immunobiotechnology, modelling and bioinformatics. As part of the common course, students will learn the economic management of a scientific project, with a focus on the construction of a business plan and cost analysis. The Master's program devotes a long period of time, almost the entire second year, to laboratory activities in which the student, under the supervision of a tutor, will independently develop and apply different experimental approaches in the context of a larger research project. This activity will be aimed at preparing for the final examination of the degree course.
The objective of the course is to provide the scientific community with experts in the fields of medical biotechnology and molecular medicine able to develop new experimental models for the study of human diseases, to develop new diagnostic approaches, to identify new therapeutic molecules, to devise innovative drug delivery systems. All these possibilities arise from the competences of the Master's graduate who will have a strong translational educational background that will allow her/him to represent a fruitful interface with the clinics, building a bridge between the bench and the bedside. A deep knowledge of the pathogenetic mechanisms of diseases is required in order to apply basic disciplines to the management of medical problems.
Employment opportunities: public and private research structures, including Universities, CNR (National Research Council), Istituto Superiore di Sanità (National Institute for health); hospitals; private pharmaceutical, diagnostic and biotechnological companies; companies supporting scientific research (instruments, biotechnological reagents); companies involved in science communication and publishing.
Below a list of professional profiles:
Medical Science Liaison (MSL) within pharmaceutical and biotechnological companies
In the pharmaceutical and biotechnological companies, this new professional figure has the role of establishing scientific relationships with clinicians, supporting the appropriate use of the drugs of interest for the company. This professional has a strong medical and pharmacological background that enable her/him to talk with physicians in order to solve clinical problems related to the use of specific drugs.
Clinical Monitor within pharmaceutical and biotechnological companies; CRO (Clinical Research Organization) (upon completion of a specific training course)
Thanks to the strong background in pharmacology and statistics this expert will be able to coordinate clinical studies. Market Access Manager within pharmaceutical and biotechnological companies; consulting agencies, AIFA (Italian agency for drugs) (upon completion of a specific training course)
Thanks to the strong background in economy and pharmacology, and a knowledge of ethical issues related to commercialization of drugs, the graduate will be in the ideal position to establish stable relationships with the Regulatory Authorities and, in general, with the Institutions with the aim of promoting the approval and the access to the market of new pharmacological and biotechnological products.
Medical and scientific communication advisor within scientific and medical communication agencies and publishers Thanks to the multidisciplinary approaches to medical sciences acquired during the course, the Master Program graduate may evolve into a medical writer or a consultant for the development of distance learning modules for the Continuing Medical Education (CME) or other health professionals requiring continuing education or again as an advisor for pharmaceutical and biotechnological companies in the communication with patient organizations.
Research scientist, after having been enrolled in PhD programs, second level Master degrees, Specialization School in Medical Genetics, Medical Pharmacology, Clinical Biochemistry, Microbiology and Virology, Nutrition. After the State Board Examination, the graduates can enter into the Professional Register of Biologists (Senior Section).
Employment statistics (Almalaurea)
Employment opportunities: public and private research structures, including Universities, CNR (National Research Council), Istituto Superiore di Sanità (National Institute for health); hospitals; private pharmaceutical, diagnostic and biotechnological companies; companies supporting scientific research (instruments, biotechnological reagents); companies involved in science communication and publishing.
Below a list of professional profiles:
Medical Science Liaison (MSL) within pharmaceutical and biotechnological companies
In the pharmaceutical and biotechnological companies, this new professional figure has the role of establishing scientific relationships with clinicians, supporting the appropriate use of the drugs of interest for the company. This professional has a strong medical and pharmacological background that enable her/him to talk with physicians in order to solve clinical problems related to the use of specific drugs.
Clinical Monitor within pharmaceutical and biotechnological companies; CRO (Clinical Research Organization) (upon completion of a specific training course)
Thanks to the strong background in pharmacology and statistics this expert will be able to coordinate clinical studies. Market Access Manager within pharmaceutical and biotechnological companies; consulting agencies, AIFA (Italian agency for drugs) (upon completion of a specific training course)
Thanks to the strong background in economy and pharmacology, and a knowledge of ethical issues related to commercialization of drugs, the graduate will be in the ideal position to establish stable relationships with the Regulatory Authorities and, in general, with the Institutions with the aim of promoting the approval and the access to the market of new pharmacological and biotechnological products.
Medical and scientific communication advisor within scientific and medical communication agencies and publishers Thanks to the multidisciplinary approaches to medical sciences acquired during the course, the Master Program graduate may evolve into a medical writer or a consultant for the development of distance learning modules for the Continuing Medical Education (CME) or other health professionals requiring continuing education or again as an advisor for pharmaceutical and biotechnological companies in the communication with patient organizations.
Research scientist, after having been enrolled in PhD programs, second level Master degrees, Specialization School in Medical Genetics, Medical Pharmacology, Clinical Biochemistry, Microbiology and Virology, Nutrition. After the State Board Examination, the graduates can enter into the Professional Register of Biologists (Senior Section).
Employment statistics (Almalaurea)
The Master's Degree Program in Medical Biotechnology and Molecular Medicine supports international mobility through collaborations with leading international universities and offers students the opportunity to earn academic credits through educational and training exchanges with partner institutions.
Available programs include:
- Bilateral agreements within the Erasmus+ framework with the University of Leuven (Katholieke Universiteit Leuven, Belgium), the Leiden University Medical Center (LUMC), University of Leiden (the Netherlands), and the University of Cantabria (Universidad de Cantabria, Spain);
- Traineeships at the Institute for Research in Biomedicine (IRB), Bellinzona, Switzerland.
In recent years, an increasing number of students have enhanced their professional skills and strengthened the European dimension of their education through periods of study and research abroad. Partner universities are highly recognized European institutions, hosting well-established Master's and PhD programs in biomedical sciences and offering opportunities to conduct research across a broad range of scientific fields covered by the Degree Program. These experiences provide students with valuable opportunities to strengthen their curricula and to explore the possibility of pursuing an international career.
The Master's Degree Program in Medical Biotechnology and Molecular Medicine allows second-year students to complete their entire practical training for the preparation of the final thesis at one of the for ementioned partner institutions, or at other institutions with which a formal agreement has been established. Students are required to define a research project consistent with their course of study and curriculum, subject to joint approval by both the University of Milan tutor and the host institution tutor.
The period abroad has a duration of up to 9 months and corresponds to 32 ECTS credits. A positive evaluation of the period abroad is required and must be jointly issued by the host institution tutor and the University of Milan tutor and subsequently approved by the Degree Program Teaching Committee. Erasmus students who achieve outstanding results, as documented by the official evaluation letter from the host institution tutor addressed to the President of the Master's Degree Program Committee, may be awarded 1 additional point in the final degree grade.
In addition to general informational meetings organized by the University, the Degree Program in Medical Biotechnology and Molecular Medicine provides specific support to interested and selected students through dedicated information sessions and individual meetings with the mobility tutors.
Available programs include:
- Bilateral agreements within the Erasmus+ framework with the University of Leuven (Katholieke Universiteit Leuven, Belgium), the Leiden University Medical Center (LUMC), University of Leiden (the Netherlands), and the University of Cantabria (Universidad de Cantabria, Spain);
- Traineeships at the Institute for Research in Biomedicine (IRB), Bellinzona, Switzerland.
In recent years, an increasing number of students have enhanced their professional skills and strengthened the European dimension of their education through periods of study and research abroad. Partner universities are highly recognized European institutions, hosting well-established Master's and PhD programs in biomedical sciences and offering opportunities to conduct research across a broad range of scientific fields covered by the Degree Program. These experiences provide students with valuable opportunities to strengthen their curricula and to explore the possibility of pursuing an international career.
The Master's Degree Program in Medical Biotechnology and Molecular Medicine allows second-year students to complete their entire practical training for the preparation of the final thesis at one of the for ementioned partner institutions, or at other institutions with which a formal agreement has been established. Students are required to define a research project consistent with their course of study and curriculum, subject to joint approval by both the University of Milan tutor and the host institution tutor.
The period abroad has a duration of up to 9 months and corresponds to 32 ECTS credits. A positive evaluation of the period abroad is required and must be jointly issued by the host institution tutor and the University of Milan tutor and subsequently approved by the Degree Program Teaching Committee. Erasmus students who achieve outstanding results, as documented by the official evaluation letter from the host institution tutor addressed to the President of the Master's Degree Program Committee, may be awarded 1 additional point in the final degree grade.
In addition to general informational meetings organized by the University, the Degree Program in Medical Biotechnology and Molecular Medicine provides specific support to interested and selected students through dedicated information sessions and individual meetings with the mobility tutors.
Students are required to attend all teaching activities, with a maximum allowance of 25% absence. Attendance must be recorded by signing in at each learning activity. In cases where absences exceed 25% of the scheduled hours, the Teaching Committee will take the appropriate measures.
Enrolment
Enrollment in this Master's Degree Program is limited, as admission is subject to a locally capped number of places. Italian and European applicants admitted to the program are selected through a ranking list based on the results of an admission test. The same ranking list may be also used for curriculum selection, in cases where student enrollment across the different curricula is not evenly distributed. To be eligible for enrollment and inclusion in the ranking list, applicants must achieve a minimum score of 20/50 on the admission test. Information regarding non-European applicants is provided below.* The date of the admission test will be announced in the official selection notice published on the University of Milan website.
For Italian and European applicants, selection is based on a competitive written entrance examination. The admission test consists of a multiple-choice written exam conducted in English and includes 50 questions covering subjects such as biology, biochemistry, physics, pharmacology, immunology, pathology, and genetics.
For non-EU applicants residing abroad (i.e., applicants requiring a student visa), selection and ranking are based on the evaluation of the applicant's academic and personal background, as well as on the outcome of an interview.
B2 entrance level:
Proficiency in English at a B2 level or higher per the Common European Framework of Reference for Languages (CEFR) is required for admission.
The B2-level requirement will be ascertained by the University Language Centre (SLAM) upon admission as follows:
- Language certificate of B2 or higher level issued no more than three years before the date of admission application. You will find the list of language certificates recognized by the University at: https://www.unimi.it/en/node/39322. The certificate must be uploaded when submitting the online application;
- English level achieved during a University of Milan degree programme and certified by the University Language Centre (SLAM) no more than four years before the date of admission application, including levels based on language certificates submitted by the applicant during their Bachelor's degree at the University of Milan. In this case the process is automatic, the applicant does not have to attach any certificates to the application;
- Entry test administrated by the University Language Centre (SLAM) according to the calendar published on the website: (https://www.unimi.it/en/node/39267/)
All those who fail to submit a valid certificate or do not meet the required proficiency level will be instructed during the admission procedure to take the Entry test.
Applicants who do not take or pass the Entry test will be required to obtain a language proficiency certificate recognized by the University (see https://www.unimi.it/en/node/39322) and deliver it to the SLAM via the InformaStudenti service by the deadline fixed for the master's programme (https://www.unimi.it/en/node/39267/).
Applicants who do not meet the requirement by said deadline will not be admitted to the master's degree programme and may not sit any further tests. To be eligible for the entrance examination, applicants holding a Bachelor's degree from Italian or EU universities must have earned 180 ECTS credits. Of these, at least 50 ECTS credits must be obtained in the following scientific disciplinary areas: BIOS-06/A (Physiology), BIOS-07/A (Biochemistry), BIOS-08/A (Molecular Biology), BIOS-09/A (Clinical Biochemistry), BIOS-10/A (Biology), BIOS-11/A (Pharmacology), BIOS-12/A (Human Anatomy), BIOS-14/A (Genetics), BIOS-15/A (General Microbiology), MEDS-24/A (Medical Statistics), MEDS-01/A (Human Genetics), MEDS-02/A (General Pathology), MEDS-02/B (Clinical Pathology), MEDS-09/A (Medical Oncology), MEDS-03/A (Microbiology), MEDS-04/A (Pathology), MEDS-05/A (Internal Medicine), MEDS-11/A (Mental Health), MEDS-12/A (Neurology), MEDS-26/A (Laboratory Medicine), INF-01/A (Informatics), and PHYS-06/A (Medical Physics).
For non-EU applicants residing abroad (i.e., applicants requiring a student visa), admission to the Master's Degree Program is based on the evaluation of the applicant's academic and personal background, as well as on the outcome of an interview. As for Italian and EU applicants, non-EU candidates must have earned at least 50 ECTS credits in the scientific disciplinary areas listed above. In order to successfully attend the learning activities of the program, applicants are required to have a good mastery of spoken and written English. A B2 level of English proficiency is mandatory, and the relevant certification must be provided at the time of registration for the entrance examination.
Students waiting to obtain the bachelor's degree, can participate in the admission test "sub iudice". In case of success, they will be accepted only if they obtain the bachelor degree by December 31th, also possessing the prerequisite described above. More details about the selection/admission procedure can be found above in the Admission Criteria paragraph.
For Italian and European applicants, selection is based on a competitive written entrance examination. The admission test consists of a multiple-choice written exam conducted in English and includes 50 questions covering subjects such as biology, biochemistry, physics, pharmacology, immunology, pathology, and genetics.
For non-EU applicants residing abroad (i.e., applicants requiring a student visa), selection and ranking are based on the evaluation of the applicant's academic and personal background, as well as on the outcome of an interview.
B2 entrance level:
Proficiency in English at a B2 level or higher per the Common European Framework of Reference for Languages (CEFR) is required for admission.
The B2-level requirement will be ascertained by the University Language Centre (SLAM) upon admission as follows:
- Language certificate of B2 or higher level issued no more than three years before the date of admission application. You will find the list of language certificates recognized by the University at: https://www.unimi.it/en/node/39322. The certificate must be uploaded when submitting the online application;
- English level achieved during a University of Milan degree programme and certified by the University Language Centre (SLAM) no more than four years before the date of admission application, including levels based on language certificates submitted by the applicant during their Bachelor's degree at the University of Milan. In this case the process is automatic, the applicant does not have to attach any certificates to the application;
- Entry test administrated by the University Language Centre (SLAM) according to the calendar published on the website: (https://www.unimi.it/en/node/39267/)
All those who fail to submit a valid certificate or do not meet the required proficiency level will be instructed during the admission procedure to take the Entry test.
Applicants who do not take or pass the Entry test will be required to obtain a language proficiency certificate recognized by the University (see https://www.unimi.it/en/node/39322) and deliver it to the SLAM via the InformaStudenti service by the deadline fixed for the master's programme (https://www.unimi.it/en/node/39267/).
Applicants who do not meet the requirement by said deadline will not be admitted to the master's degree programme and may not sit any further tests. To be eligible for the entrance examination, applicants holding a Bachelor's degree from Italian or EU universities must have earned 180 ECTS credits. Of these, at least 50 ECTS credits must be obtained in the following scientific disciplinary areas: BIOS-06/A (Physiology), BIOS-07/A (Biochemistry), BIOS-08/A (Molecular Biology), BIOS-09/A (Clinical Biochemistry), BIOS-10/A (Biology), BIOS-11/A (Pharmacology), BIOS-12/A (Human Anatomy), BIOS-14/A (Genetics), BIOS-15/A (General Microbiology), MEDS-24/A (Medical Statistics), MEDS-01/A (Human Genetics), MEDS-02/A (General Pathology), MEDS-02/B (Clinical Pathology), MEDS-09/A (Medical Oncology), MEDS-03/A (Microbiology), MEDS-04/A (Pathology), MEDS-05/A (Internal Medicine), MEDS-11/A (Mental Health), MEDS-12/A (Neurology), MEDS-26/A (Laboratory Medicine), INF-01/A (Informatics), and PHYS-06/A (Medical Physics).
For non-EU applicants residing abroad (i.e., applicants requiring a student visa), admission to the Master's Degree Program is based on the evaluation of the applicant's academic and personal background, as well as on the outcome of an interview. As for Italian and EU applicants, non-EU candidates must have earned at least 50 ECTS credits in the scientific disciplinary areas listed above. In order to successfully attend the learning activities of the program, applicants are required to have a good mastery of spoken and written English. A B2 level of English proficiency is mandatory, and the relevant certification must be provided at the time of registration for the entrance examination.
Students waiting to obtain the bachelor's degree, can participate in the admission test "sub iudice". In case of success, they will be accepted only if they obtain the bachelor degree by December 31th, also possessing the prerequisite described above. More details about the selection/admission procedure can be found above in the Admission Criteria paragraph.
Places available: 65 + 10 reserved for non-EU citizens
Call for applications
Please refer to the call for admission test dates and contents, and how to register.
Application for admission: from 24/03/2026 to 25/08/2026
Application for matriculation: from 17/09/2026 to 24/09/2026
Online services
Learn more:
Programme description and courses list
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced Microscopic Techniques and Nanotechnology | 6 | 51 | English | PHYS-06/A |
| Applied Pharmacology to Biotechnology | 7 | 67 | English | BIOS-11/A |
| Pathogenetic Basis of Diseases | 12 | 84 | English | MEDS-02/A MEDS-05/A MEDS-08/A |
| - General pathology and immunology | 6 | 42 | MEDS-02/A | |
| - Internal medicine and endocrinology | 6 | 42 | MEDS-05/A,MEDS-08/A | |
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and Molecular Bases of Diseases | 14 | 111.5 | English | BIOS-10/A MEDS-01/A |
| - Biology | 8 | 69.5 | BIOS-10/A | |
| - Medical genetics | 6 | 42 | MEDS-01/A | |
| Human Biochemistry | 9 | 76.5 | English | BIOS-07/A |
| Molecular Biology Applied to Biotechnology | 7 | 67 | English | BIOS-08/A |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Molecular Diagnostics and Therapy | 6 | 42 | English | BIOS-10/A BIOS-11/A MEDS-12/A MEDS-26/D |
| Neurobiology | 6 | 42 | English | BIOS-06/A BIOS-07/A BIOS-10/A MEDS-12/A |
| Pathogenetic Bases of Neurological and Psychiatric Disorders | 6 | 42 | English | BIOS-08/A MEDS-08/A MEDS-11/A MEDS-12/A |
Study plan rules
1° anno - In the first year, the student must gain 4 ects of further electives
be activated by the A.Y. 2027/2028
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further Learning Activities (linguistic, informatic, relational) | 3 | 48 | English | NN |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Social Aspects of Biotechnology | 11 | 77 | English | MEDS-02/C |
| - Bio-medicine | 5 | 35 | MEDS-02/C | |
| - History of medicine | 6 | 42 | MEDS-02/C | |
Conclusive activities
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing Training Activities | 4 | 100 | English | NN |
| Degree Program Final Exam | 21 | 0 | English | NN |
Study plan rules
2° anno - In the second year, the student must gain 4 ects of further electives
Open sessions
There are no specific sessions for these activities.
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Optional | ||||
| Additional Language Skills: Italian (3 ECTS) | 3 | 0 | Italian | NN |
Before enrolling in curriculum-specific examinations, students must have successfully completed the 6 common examinations offered during the first two terms. Likewise, access to laboratory activities is granted only after passing the 6 common examinations of the first two terms.
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced Microscopic Techniques and Nanotechnology | 6 | 51 | English | PHYS-06/A |
| Applied Pharmacology to Biotechnology | 7 | 67 | English | BIOS-11/A |
| Pathogenetic Basis of Diseases | 12 | 84 | English | MEDS-02/A MEDS-05/A MEDS-08/A |
| - General pathology and immunology | 6 | 42 | MEDS-02/A | |
| - Internal medicine and endocrinology | 6 | 42 | MEDS-05/A,MEDS-08/A | |
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and Molecular Bases of Diseases | 14 | 111.5 | English | BIOS-10/A MEDS-01/A |
| - Biology | 8 | 69.5 | BIOS-10/A | |
| - Medical genetics | 6 | 42 | MEDS-01/A | |
| Human Biochemistry | 9 | 76.5 | English | BIOS-07/A |
| Molecular Biology Applied to Biotechnology | 7 | 67 | English | BIOS-08/A |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Cancer Epidemiology and Pathogenesis | 6 | 42 | English | MEDS-02/A MEDS-09/A MEDS-09/B MEDS-24/A |
| Cancer Immunology and Microenvironment | 6 | 42 | English | MEDS-02/A MEDS-09/A MEDS-09/B |
| Research and Development of New Diagnostic and Therapeutic Methodologies | 6 | 51 | English | BIOS-08/A MEDS-04/A MEDS-09/B MEDS-26/D |
Study plan rules
1° anno - In the first year, the student must gain 4 ects of further electives
be activated by the A.Y. 2027/2028
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further Learning Activities (linguistic, informatic, relational) | 3 | 48 | English | NN |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Social Aspects of Biotechnology | 11 | 77 | English | MEDS-02/C |
| - Bio-medicine | 5 | 35 | MEDS-02/C | |
| - History of medicine | 6 | 42 | MEDS-02/C | |
Conclusive activities
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing Training Activities | 4 | 100 | English | NN |
| Degree Program Final Exam | 21 | 0 | English | NN |
Study plan rules
2° anno - In the second year, the student must gain 4 ects of further electives
Open sessions
There are no specific sessions for these activities.
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Optional | ||||
| Additional Language Skills: Italian (3 ECTS) | 3 | 0 | Italian | NN |
Before enrolling in curriculum-specific examinations, students must have successfully completed the 6 common examinations offered during the first two terms. Likewise, access to laboratory activities is granted only after passing the 6 common examinations of the first two terms.
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced Microscopic Techniques and Nanotechnology | 6 | 51 | English | PHYS-06/A |
| Applied Pharmacology to Biotechnology | 7 | 67 | English | BIOS-11/A |
| Pathogenetic Basis of Diseases | 12 | 84 | English | MEDS-02/A MEDS-05/A MEDS-08/A |
| - General pathology and immunology | 6 | 42 | MEDS-02/A | |
| - Internal medicine and endocrinology | 6 | 42 | MEDS-05/A,MEDS-08/A | |
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and Molecular Bases of Diseases | 14 | 111.5 | English | BIOS-10/A MEDS-01/A |
| - Biology | 8 | 69.5 | BIOS-10/A | |
| - Medical genetics | 6 | 42 | MEDS-01/A | |
| Human Biochemistry | 9 | 76.5 | English | BIOS-07/A |
| Molecular Biology Applied to Biotechnology | 7 | 67 | English | BIOS-08/A |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced Techniques in Medical Biotechnology | 6 | 42 | English | BIOS-07/A BIOS-08/A BIOS-10/A MEDS-21/A |
| Data and Laboratory Management | 6 | 42 | English | MEDS-24/A MEDS-25/A MEDS-26/A |
| Molecular Diagnostics | 6 | 42 | English | BIOS-09/A MEDS-01/A MEDS-03/A |
Study plan rules
1° anno - In the first year, the student must gain 4 ects of further electives
be activated by the A.Y. 2027/2028
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further Learning Activities (linguistic, informatic, relational) | 3 | 48 | English | NN |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Social Aspects of Biotechnology | 11 | 77 | English | MEDS-02/C |
| - Bio-medicine | 5 | 35 | MEDS-02/C | |
| - History of medicine | 6 | 42 | MEDS-02/C | |
Conclusive activities
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing Training Activities | 4 | 100 | English | NN |
| Degree Program Final Exam | 21 | 0 | English | NN |
Study plan rules
2° anno - In the second year, the student must gain 4 ects of further electives
Open sessions
There are no specific sessions for these activities.
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Optional | ||||
| Additional Language Skills: Italian (3 ECTS) | 3 | 0 | Italian | NN |
Before enrolling in curriculum-specific examinations, students must have successfully completed the 6 common examinations offered during the first two terms. Likewise, access to laboratory activities is granted only after passing the 6 common examinations of the first two terms.
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced Microscopic Techniques and Nanotechnology | 6 | 51 | English | PHYS-06/A |
| Applied Pharmacology to Biotechnology | 7 | 67 | English | BIOS-11/A |
| Pathogenetic Basis of Diseases | 12 | 84 | English | MEDS-02/A MEDS-05/A MEDS-08/A |
| - General pathology and immunology | 6 | 42 | MEDS-02/A | |
| - Internal medicine and endocrinology | 6 | 42 | MEDS-05/A,MEDS-08/A | |
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and Molecular Bases of Diseases | 14 | 111.5 | English | BIOS-10/A MEDS-01/A |
| - Biology | 8 | 69.5 | BIOS-10/A | |
| - Medical genetics | 6 | 42 | MEDS-01/A | |
| Human Biochemistry | 9 | 76.5 | English | BIOS-07/A |
| Molecular Biology Applied to Biotechnology | 7 | 67 | English | BIOS-08/A |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Cancer Immunology and Microenvironment | 6 | 42 | English | MEDS-02/A MEDS-09/A MEDS-09/B |
| Experimental Immunology and Immunobiotechnology | 6 | 42 | English | MEDS-02/A MEDS-09/C MEDS-26/A MVET-03/A |
| Transplantation and Tissue Engineering | 6 | 51 | English | IBIO-01/A MEDS-06/A MEDS-09/B MEDS-25/A |
Study plan rules
1° anno - In the first year, the student must gain 4 ects of further electives
be activated by the A.Y. 2027/2028
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further Learning Activities (linguistic, informatic, relational) | 3 | 48 | English | NN |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Social Aspects of Biotechnology | 11 | 77 | English | MEDS-02/C |
| - Bio-medicine | 5 | 35 | MEDS-02/C | |
| - History of medicine | 6 | 42 | MEDS-02/C | |
Conclusive activities
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing Training Activities | 4 | 100 | English | NN |
| Degree Program Final Exam | 21 | 0 | English | NN |
Study plan rules
2° anno - In the second year, the student must gain 4 ects of further electives
Open sessions
There are no specific sessions for these activities.
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Optional | ||||
| Additional Language Skills: Italian (3 ECTS) | 3 | 0 | Italian | NN |
Before enrolling in curriculum-specific examinations, students must have successfully completed the 6 common examinations offered during the first two terms. Likewise, access to laboratory activities is granted only after passing the 6 common examinations of the first two terms.
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Advanced Microscopic Techniques and Nanotechnology | 6 | 51 | English | PHYS-06/A |
| Applied Pharmacology to Biotechnology | 7 | 67 | English | BIOS-11/A |
| Pathogenetic Basis of Diseases | 12 | 84 | English | MEDS-02/A MEDS-05/A MEDS-08/A |
| - General pathology and immunology | 6 | 42 | MEDS-02/A | |
| - Internal medicine and endocrinology | 6 | 42 | MEDS-05/A,MEDS-08/A | |
Second trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Genetic and Molecular Bases of Diseases | 14 | 111.5 | English | BIOS-10/A MEDS-01/A |
| - Biology | 8 | 69.5 | BIOS-10/A | |
| - Medical genetics | 6 | 42 | MEDS-01/A | |
| Human Biochemistry | 9 | 76.5 | English | BIOS-07/A |
| Molecular Biology Applied to Biotechnology | 7 | 67 | English | BIOS-08/A |
Third trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| In Vitro and in Vivo Model Systems for Human Diseases Modeling | 6 | 42 | English | BIOS-08/A BIOS-10/A BIOS-11/A MEDS-02/A |
| Multilevel Computational Modelling of Human Diseases | 6 | 42 | English | BIOS-08/A CHEM-02/A PHYS-06/A |
| Spatial and Molecular Organization of Cells in Diseases | 6 | 42 | English | BIOS-06/A BIOS-07/A BIOS-08/A PHYS-06/A |
Study plan rules
1° anno - In the first year, the student must gain 4 ects of further electives
be activated by the A.Y. 2027/2028
year
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Further Learning Activities (linguistic, informatic, relational) | 3 | 48 | English | NN |
First trimester
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Social Aspects of Biotechnology | 11 | 77 | English | MEDS-02/C |
| - Bio-medicine | 5 | 35 | MEDS-02/C | |
| - History of medicine | 6 | 42 | MEDS-02/C | |
Conclusive activities
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Compulsory | ||||
| Professionalizing Training Activities | 4 | 100 | English | NN |
| Degree Program Final Exam | 21 | 0 | English | NN |
Study plan rules
2° anno - In the second year, the student must gain 4 ects of further electives
Open sessions
There are no specific sessions for these activities.
| Courses or activities | Max ECTS | Total hours | Language | SSD |
|---|---|---|---|---|
| Optional | ||||
| Additional Language Skills: Italian (3 ECTS) | 3 | 0 | Italian | NN |
Before enrolling in curriculum-specific examinations, students must have successfully completed the 6 common examinations offered during the first two terms. Likewise, access to laboratory activities is granted only after passing the 6 common examinations of the first two terms.
Learn more
Guidance:
Admission, ranking and enrolment
Milan
Course locations
Both common learning activities and Curricular learning activities will be held at the Dipartimento di Biotecnologie Mediche e Medicina Traslazionale - Via Fratelli Cervi, 93 - 20054 Segrate.
Academic guidance tutor
Erasmus and international mobility tutor
Internship tutor
Quality Assurance Delegate
Reference structures
Contacts
- Student secretary: Mrs Lucia Loseto
Dip. Biotecnologie Mediche e Medicina Traslazionale sede di via Vanvitelli, 32
http://medicalbiotechnology.cdl.unimi.it/en
[email protected]
+390250317123
For students enrolled in Bachelor's, Master's and single-cycle degree programmes, tuition fees are to be paid in two instalments:
- the amount of the first instalment is the same for all students and is due upon enrolment
- the amount of the second instalment varies according to each student's ISEE University value and the degree programme in which they are enrolled
- for international students with income and assets abroad, the second instalment varies according to their country of origin.
Education incentive programmes and other benefits
The University offers scholarships, cafeterias, subsidised accommodation and other forms of financial support to students meeting specific economic and merit requirements.
More information
Official documents